243 related articles for article (PubMed ID: 26410834)
1. The impact of follicular fluid adiponectin and ghrelin levels based on BMI on IVF outcomes in PCOS.
Inal HA; Yilmaz N; Gorkem U; Oruc AS; Timur H
J Endocrinol Invest; 2016 Apr; 39(4):431-7. PubMed ID: 26410834
[TBL] [Abstract][Full Text] [Related]
2. Ovarian HMW adiponectin is associated with folliculogenesis in women with polycystic ovary syndrome.
Tao T; Xu B; Liu W
Reprod Biol Endocrinol; 2013 Oct; 11():99. PubMed ID: 24144083
[TBL] [Abstract][Full Text] [Related]
3. Resistin levels of serum and follicular fluid in non-obese patients with polycystic ovary syndrome during IVF cycles.
Lu XE; Huang HF; Li MG; Zhu YM; Qiang YL; Dong MY
J Zhejiang Univ Sci B; 2005 Sep; 6(9):897-902. PubMed ID: 16130192
[TBL] [Abstract][Full Text] [Related]
4. Predicting the outcome of different protocols of in vitro fertilization with anti-Muüllerian hormone levels in patients with polycystic ovary syndrome.
Chen Y; Ye B; Yang X; Zheng J; Lin J; Zhao J
J Int Med Res; 2017 Jun; 45(3):1138-1147. PubMed ID: 28449632
[TBL] [Abstract][Full Text] [Related]
5. Effect of body mass index on in vitro fertilization outcomes in women with polycystic ovary syndrome.
Bailey AP; Hawkins LK; Missmer SA; Correia KF; Yanushpolsky EH
Am J Obstet Gynecol; 2014 Aug; 211(2):163.e1-6. PubMed ID: 24657792
[TBL] [Abstract][Full Text] [Related]
6. Adropin levels in women with polycystic ovaries undergoing ovarian stimulation: correlation with lipoprotein lipid profiles.
Bousmpoula A; Kouskouni E; Benidis E; Demeridou S; Kapeta-Kourkouli R; Chasiakou A; Baka S
Gynecol Endocrinol; 2018 Feb; 34(2):153-156. PubMed ID: 28937295
[TBL] [Abstract][Full Text] [Related]
7. The effect of follicular antimullerian hormone levels of non-obese, non-hyperandrogenemic polycystic ovary syndrome patients on assisted reproduction outcome.
Yilmaz N; Uygur D; Dogan M; Ozgu E; Salman B; Mollamahmutoglu L
Gynecol Endocrinol; 2012 Mar; 28(3):162-5. PubMed ID: 22103791
[TBL] [Abstract][Full Text] [Related]
8. [Predictive value of anti-Mullerian hormone levels in serum and follicle fluid for IVF-ET outcomes in patients with polycystic ovarian syndrome].
Chen X; Yin M; Ye D; He Y; Chen S
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Apr; 33(4):546-9. PubMed ID: 23644117
[TBL] [Abstract][Full Text] [Related]
9. Serum and follicular resistin levels in women with polycystic ovarian syndrome during IVF-stimulated cycles.
Seow KM; Juan CC; Hsu YP; Ho LT; Wang YY; Hwang JL
Hum Reprod; 2005 Jan; 20(1):117-21. PubMed ID: 15513972
[TBL] [Abstract][Full Text] [Related]
10. Follicular fluid total antioxidant capacity levels in PCOS.
Yilmaz N; Inal HA; Gorkem U; Sargin Oruc A; Yilmaz S; Turkkani A
J Obstet Gynaecol; 2016 Jul; 36(5):654-7. PubMed ID: 26911305
[TBL] [Abstract][Full Text] [Related]
11. [Concentration of steroid hormones in the follicular fluid of mature and immature ovarian follicles of patients with polycystic ovary syndrome submitted to in vitro fertilization].
de Resende LO; dos Reis RM; Ferriani RA; Vireque AA; Santana LF; de Sá Rosa e Silva AC; Martins Wde P
Rev Bras Ginecol Obstet; 2010 Sep; 32(9):447-53. PubMed ID: 21271150
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of adiponectin system in granulosa cells and low levels of HMW adiponectin in PCOS.
Artimani T; Saidijam M; Aflatoonian R; Ashrafi M; Amiri I; Yavangi M; SoleimaniAsl S; Shabab N; Karimi J; Mehdizadeh M
J Assist Reprod Genet; 2016 Jan; 33(1):101-10. PubMed ID: 26631404
[TBL] [Abstract][Full Text] [Related]
13. Follicular fluid levels of anti-Mullerian hormone as a predictor of oocyte maturation, fertilization rate, and embryonic development in patients with polycystic ovary syndrome.
Mashiach R; Amit A; Hasson J; Amzalzg S; Almog B; Ben-Yosef D; Lessing JB; Limor R; Azem F
Fertil Steril; 2010 May; 93(7):2299-302. PubMed ID: 19261276
[TBL] [Abstract][Full Text] [Related]
14. Serum and follicular fluid irisin levels in women with polycystic ovaries undergoing ovarian stimulation: correlation with insulin resistance and lipoprotein lipid profiles.
Bousmpoula A; Benidis E; Demeridou S; Kapeta-Kourkouli R; Chasiakou A; Chasiakou S; Kouskouni E; Baka S
Gynecol Endocrinol; 2019 Sep; 35(9):803-806. PubMed ID: 30982370
[TBL] [Abstract][Full Text] [Related]
15. Follicular fluid norepinephrine and dopamine concentrations are higher in polycystic ovary syndrome.
Musalı N; Özmen B; Şükür YE; Ergüder Bİ; Atabekoğlu CS; Sönmezer M; Berker B; Aytaç R
Gynecol Endocrinol; 2016 Jun; 32(6):460-3. PubMed ID: 26754116
[TBL] [Abstract][Full Text] [Related]
16. IL-18 and IL-18 binding protein concentration in ovarian follicular fluid of women with unexplained infertility to PCOS during in vitro fertilization.
Zhang H; Wang X; Xu J; Zhu Y; Chen X; Hu Y
J Reprod Immunol; 2020 Apr; 138():103083. PubMed ID: 31991315
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls.
Glintborg D; Andersen M; Hagen C; Frystyk J; Hulstrøm V; Flyvbjerg A; Hermann AP
Eur J Endocrinol; 2006 Aug; 155(2):337-45. PubMed ID: 16868149
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-β1 and its receptor soluble endoglin are altered in polycystic ovary syndrome during controlled ovarian stimulation.
Tal R; Seifer DB; Shohat-Tal A; Grazi RV; Malter HE
Fertil Steril; 2013 Aug; 100(2):538-43. PubMed ID: 23684116
[TBL] [Abstract][Full Text] [Related]
19. Follicular fluid cytokine composition and oocyte quality of polycystic ovary syndrome patients with metabolic syndrome undergoing in vitro fertilization.
Niu Z; Ye Y; Xia L; Feng Y; Zhang A
Cytokine; 2017 Mar; 91():180-186. PubMed ID: 28082237
[TBL] [Abstract][Full Text] [Related]
20. Altered redox status may contribute to aberrant folliculogenesis and poor reproductive outcomes in women with polycystic ovary syndrome.
Naigaonkar A; Dadachanji R; Hinduja I; Mukherjee S
J Assist Reprod Genet; 2021 Oct; 38(10):2609-2623. PubMed ID: 34041658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
